Fig. 5From: Design, synthesis, and biological evaluation of chalcones for anticancer properties targeting glycogen synthase kinase 3 betaCompound 14 inhibits EMT in MCF-7SC cells. A, B) Migration capacity was evaluated using a wound-healing assay following compound 14 treatment for 12 h and 24 h. Quantification of migrated cells normalized to control. C, D Expression of EMT markers was detected by western blotting following treatment with compound 14 for 24 h. β –actin was used as a loading controlBack to article page